ALERT: A Phase II Study of Alternating Eribulin and Hormonal Therapy in Pre-treated ER+ve Breast Cancer.
Clinical trial NCT02681523 · TERMINATED
Trial details
- NCT number
- NCT02681523
- Sponsor
- Imperial College London
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-28
- Primary completion
- 2018-07-24
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.